A61P 33 - Antiparasitic agents

Patents for A61P 33 - Antiparasitic agents (21,787)
11/2001
11/29/2001	US20010046483 Medicaments for manipulating T-cell immune response
11/29/2001	EP1143941A3 Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections
11/29/2001	CA2429199A1 Drug metabolizing enzymes
11/29/2001	CA2407570A1 Compositions and methods for delivery of a molecule into a cell
11/28/2001	EP1157094A2 Method for the purification, recovery, and sporulation of cysts and oocysts
11/28/2001	EP1156817A1 Controlling protein levels in eucaryotic organisms
11/28/2001	CN1075499C Quninolone-acid naphthyridone carboxylic acid derivatives
11/27/2001	US6323210 Transferase inhibitor
11/27/2001	US6323176 Cyclic peptide antifungal agents
11/27/2001	US6322976 Compositions and methods of disease diagnosis and therapy
11/27/2001	CA2045864C Stable salts of 4"-deoxy-4" epi-methylamino avermectin bla/blb
11/22/2001	WO2001088106A2 Novel deoxyribonucleside kinase enzyme multi-substrate variants
11/22/2001	WO2001087849A2 Modulators of tnf- alpha signaling
11/22/2001	WO2001087839A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
11/22/2001	WO2001087328A2 Interleukin-1 inhibitors in the treatment of diseases
11/22/2001	US20010044456 Non-systemic control of parasites
11/22/2001	US20010044416 Administering an antigen and a CD4+ T helper (Th2) cell immunostimulatory nucleic acid mucosally or dermally to produce an antigen specific immune response; treating autoimmune diseases, cancer, infections
11/22/2001	CA2781858A1 Modulators of tnf-.alpha. signaling
11/22/2001	CA2408530A1 Novel deoxynucleoside kinase enzyme variants
11/22/2001	CA2408408A1 Modulators of tnf- alpha signaling
11/22/2001	CA2407258A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
11/21/2001	EP1156110A2 G-protein coupled receptor (HFGAN72Y)
11/21/2001	EP1155698A1 Organoboron compounds exhibiting anticoccidial activities
11/21/2001	EP1155025A1 Platinum (ii) compounds
11/21/2001	EP1154997A1 Pharmaceutically active compounds and methods of use thereof
11/21/2001	EP1154755A1 Liposome formulations
11/21/2001	CN1323214A Anionic or cationic dendrimer antimicrobial or antiparasitic composition
11/21/2001	CN1323161A Oral combination of lufenuron and nitenpyram against fleas
11/20/2001	US6319910 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
11/20/2001	US6319502 Immunogenic polypeptide; treating malaria
11/15/2001	WO2001085942A2 Cytoskeleton-associated proteins
11/15/2001	WO2001085677A1 Amino acid derivatives and their use as medicines
11/15/2001	WO2001085204A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	WO2001085203A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	WO2001085178A1 Nutritional preparation comprising ribose and folic acid and medical use thereof
11/15/2001	US20010041723 Using agonists and antagonists of the nicotinergic acetylcholine receptors of insects such as fleas, lice and flies, on humans and animals
11/15/2001	CA2408549A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	CA2408547A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	CA2407850A1 Cytoskeleton-associated proteins
11/15/2001	CA2407830A1 Amino acid derivatives and their use as medicines
11/14/2001	EP1153546A1 Novel use of delta-aminolevulinic acid for prevention and treatment of infection by pathogenic microorganisms and parasite
11/14/2001	EP1152768A2 TREATMENT OF CHRONIC VIRAL INFECTIONS WITH $i(M. VACCAE)
11/14/2001	EP1152734A1 Modified calycins
11/14/2001	EP0871617B1 Parasiticidal compounds
11/14/2001	EP0760648B1 Chewable flubendazole tablets for companion animals
11/14/2001	EP0675882B1 5-aryl-1,3-thiazine derivatives, manufacture thereof and use as pesticides
11/14/2001	CN1321494A Lotion for controlling crab louses
11/13/2001	US6316456 Purine derivatives having, in particular, antiproliferative properties, and their biological uses
11/13/2001	US6316000 For preventing the development of a parasite in an arthropod;for immunization
11/08/2001	WO2001083775A2 Proteases
11/08/2001	WO2001083774A2 Novel mutated form of arginine deiminase
11/08/2001	WO2001083524A2 Rna metabolism proteins
11/08/2001	WO2001083496A1 Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents
11/08/2001	WO2001082957A1 Snthetic vaccine for tick control
11/08/2001	WO2001082932A2 Methods and compositions for enhancing cellular function through protection of tissue components
11/08/2001	WO2001040195A3 Control of arthropods in animals
11/08/2001	US20010039414 Sustained release delivery systems for solutes
11/08/2001	CA2407746A1 Proteases
11/08/2001	CA2407435A1 Rna metabolism proteins
11/07/2001	EP1151118A1 Recombinant expression of heterologous nucleic acids in protozoa
11/07/2001	EP1151104A1 Diagnostic and protective antigen gene sequences of ichthyophthirius
11/07/2001	EP1151098A1 Malaria vaccine
11/07/2001	EP1151000A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
11/07/2001	EP1150710A1 Immunogenic complexes and methods relating thereto
11/07/2001	EP1150707A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS
11/07/2001	EP1150706A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response
11/07/2001	EP1150690A1 Chemical compounds
11/07/2001	EP1150689A1 Chemical compounds
11/07/2001	EP1150658A2 Method for controlling liposome size
11/06/2001	US6313156 Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors
11/06/2001	US6313100 Antibacterial, antiprotozoa agents
11/01/2001	WO2001081590A2 Protein phosphatases
11/01/2001	WO2001081358A1 The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals
11/01/2001	WO2001081339A1 Compositions for treating or preventing malaria and method of treating malaria
11/01/2001	WO2001080885A2 Equine protozoal myeloencephalitis vaccine
11/01/2001	WO2001080881A1 Vaccine comprising a tick cement protein
11/01/2001	WO2001080809A2 Medicament for the treatment of diseases caused by parasitic protozoa
11/01/2001	WO2001060381B1 Nucleoside analogs with carboxamidine-modified bicyclic base
11/01/2001	WO2001034582A3 Sordaricin derivatives having antifungal activity
11/01/2001	WO2001033966A3 Active ingredient combination having insecticidal and acaricidal characteristics
11/01/2001	WO2001010847A3 Novel integrin receptor antagonists
11/01/2001	WO2001005937A3 Conversion of a watson-crick dna to a hoogsteen-paired duplex
11/01/2001	WO2000034483A3 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	US20010036923 Complex
11/01/2001	US20010036462 Enhancing immunology response
11/01/2001	US20010036459 Cytotoxicity; therapeutic antibody
11/01/2001	US20010036452 Interleukin-1 muteins useful as vaccine adjuvants
11/01/2001	EP1144642A3 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	CA2407517A1 Equine protozoal myeloencephalitis vaccine
11/01/2001	CA2407448A1 The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals
11/01/2001	CA2406264A1 Protein phosphatases
10/2001
10/31/2001	EP1149580A1 Use of heteroaryl substituted N-(Indole-2-Carbonyl-) amides for the manufacture of a medicament for the treatment of infection
10/31/2001	CN1320117A 2-substituted heterocyclic sulfonamides
10/30/2001	US6310049 Nematicidal pyrazoles
10/30/2001	US6309663 Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
10/30/2001	US6309644 Parasitic nematode transglutaminase proteins and uses thereof
10/25/2001	WO2001079524A2 Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof
10/25/2001	WO2001079480A1 Albumin fusion proteins
10/25/2001	WO2001079444A2 Albumin fusion proteins
10/25/2001	WO2001079443A2 Albumin fusion proteins

1 ... 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 ... 218